Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
Agentic AI Boom to Drive Massive Growth in CPU Market, UBS Says 
AWS Data Center Overheating Disrupts Cloud Services in Northern Virginia 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
JD Sports Backs Nike CEO Elliott Hill Amid Brand Turnaround Efforts 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook 
China Banks Halt New Loans to Sanctioned Refineries Amid U.S.-Iran Oil Crackdown 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks 
BUENA, N.J., April 26, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday, May 7, 2018 to discuss the 1st quarter 2018 financial results and business update.
The Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.
This call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at www.teligent.com.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com
